Skip to content
HowShorted

ASSEMBLY BIOSCIENCES, INC. short interest in 2020

In 2020, ASSEMBLY BIOSCIENCES, INC.'s disclosed short interest ran from 8.85% of shares outstanding on 15 Jan 2020 to 8.26% on 31 Dec 2020, a change of -0.59 percentage points. The year's high was 12.50% on 30 Oct 2020 and its low 6.87% on 13 Mar 2020, averaging 9.82% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.21 days on 31 Aug 2020. Full history: ASSEMBLY BIOSCIENCES, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ASSEMBLY BIOSCIENCES, INC. in 2020

2020 in figures

Start of year
8.85% (15 Jan 2020)
End of year
8.26% (31 Dec 2020)
Change
-0.59 pp
High
12.50% (30 Oct 2020)
Low
6.87% (13 Mar 2020)
Average
9.82%
Highest days to cover
25.21 (31 Aug 2020)
SEC filings marked
8

Every report in 2020

ASSEMBLY BIOSCIENCES, INC. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20208.85%7.35
31 Jan 20208.83%8.36
14 Feb 20208.77%9.26
28 Feb 20208.72%9.06
13 Mar 20206.87%9.8710-K filed, results (8-K)
31 Mar 20207.55%7.17
15 Apr 20208.49%13.04
30 Apr 20209.43%19.91
15 May 20209.54%17.38results (8-K), 10-Q filed
29 May 20209.52%19.43
15 Jun 20209.57%16.30
30 Jun 202011.16%12.66
15 Jul 202011.80%25.03
31 Jul 202011.54%16.65
14 Aug 202011.32%20.5410-Q filed, results (8-K)
31 Aug 202011.34%25.21
15 Sep 202011.24%14.47
30 Sep 202011.73%13.24
15 Oct 202011.88%21.84
30 Oct 202012.50%15.82
13 Nov 20208.70%1.0010-Q filed, results (8-K)
30 Nov 20209.06%2.32
15 Dec 20209.07%3.56
31 Dec 20208.26%3.23

See also: ASSEMBLY BIOSCIENCES, INC.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.